IDH1 and central nervous system cancer: According to the 2021 WHO Classification of Tumors of the Central Nervous System, IDH-mutant astrocytoma was molecularly characterized by IDH mutations without 1p19q co-deletion and was classified as WHO grades 2–4 [1].